Stendra (avanafil) is a phosphodiesterase type 5 (PDE5) inhibitor used for the treatment of erectile dysfunction. Like other medications in this class, it may cause a range of side effects, from mild and temporary reactions to more serious complications that require medical attention. Understanding these effects helps users recognize what is typical, what may require monitoring, and when to seek professional evaluation.
Common side effects of Stendra are generally mild and tend to appear shortly after taking the medication. They often resolve as the drug’s concentration decreases in the body. These reactions typically do not require medical treatment unless they persist or become uncomfortable.
These effects are linked to the medication’s influence on blood vessel relaxation and changes in circulation. Many users find that side effects lessen over time as their body becomes accustomed to avanafil.
Less common side effects may occur due to individual sensitivity, interactions with other medications, or underlying health conditions. While these reactions are not typically dangerous, they may indicate that the dose is too strong or that the medication interacts with other factors.
If these symptoms occur frequently or interfere with daily activities, a healthcare professional may recommend adjustments or evaluate potential interactions with other treatments.
Serious side effects from Stendra are rare but require immediate medical attention. These reactions may signal a harmful response or an underlying condition that makes PDE5 inhibitors unsuitable for continued use.
These symptoms may be related to cardiovascular strain, nerve‑related complications, or rare vascular conditions. Immediate evaluation is essential to prevent long‑term harm.
Medical guidance is important both before starting Stendra and if unexpected symptoms appear during use. Users should contact a healthcare professional if they experience any concerning or persistent reactions.
Individuals taking nitrate‑based medications, those with certain cardiovascular conditions, or people with significant liver or kidney impairment should discuss risks carefully before using avanafil. Regular follow‑up helps ensure the medication remains safe, effective, and appropriate for ongoing use.
These references relate to avanafil (Spedra) dosing and clinical pharmacology. Brand names and availability may vary by region.